After initial infection, the SARS-CoV-2 virus replicates in pulmonary epithelial cells and then begins to circulate, which allows it to access more distant cells that express angiotensin-converting enzyme 2 (ACE2) and other necessary cell-entry proteins (Chung et al. 2021). Here, ACE2 is linked to infection.